Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Sirgo Insider Profile
4 Followers
Mark Sirgo, Director at BioDelivery, holds 86.98K shares in 9 Meters Biopharma (Ticker: NMTRQ), holds 0.00 shares in BioDelivery (Ticker: BDSI), holds 8.70K shares in Biomerica (Ticker: BMRA).
Profitable Transactions
10 out of 25 Profitable Transactions
Average Return
-22.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 16, 2020 - Jun 16, 2021
Return:+150.80%
The most profitable trade made by Mark Sirgo
Mark Sirgo's Trading History
BioDelivery
Mar 22, 2022
―
Uninformative Sell
―
$0.00
Biomerica
Apr 21, 2020
Director
Informative Sell
80.83K
$6.28K
9 Meters Biopharma
Mar 31, 2023
Director
Uninformative Buy
―
$1.74K
Salix
Apr 03, 2015
―
Uninformative Sell
1.10M
―
List of latest transactions for each holding click on a transaction to see Mark Sirgo's performance on stock
You May Also Like
Mark Sirgo insider profile FAQ
What is the percentage of profitable transactions made by Mark Sirgo?
The percentage of profitable transactions made by Mark Sirgo is 40%.
What is the average return per transaction made by Mark Sirgo?
The average return per transaction made by Mark Sirgo is -22.40%.
What stocks does Mark Sirgo hold?
Mark Sirgo holds: BDSI, BMRA, NMTRQ, SLXP stocks.
What was Mark Sirgo’s latest transaction?
Mark Sirgo latest transaction was an Uninformative Buy of ―.
What was Mark Sirgo's most profitable transaction?
Mark Sirgo’s most profitable transaction was an Informative Buy of NMTRQ stock on June 16, 2020. The return on the trade was 150.80%.
What is Mark Sirgo's role in BioDelivery?
Mark Sirgo's role in BioDelivery is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.